Research Events

19 Mar 2019

Organizers: IRB Barcelona

Date: Tuesday, 19 March, 15:00h

Place: Felix Serratosa room

Host: Dr. Manuel Serrano, PhD - IRB Barcelona

 

Abstract

21 Mar 2019

Organizers: IRB Barcelona
Date: Thursday 21th March, 12.00h
Place: Felix Serratosa Hall, Parc Cientific de Barcelona

Host: Salvador Aznar-Benitah, PhD - IRB Barcelona

Abstract

22 Mar 2019

This event will include talks and poster sessions presented by and for students. Furthermore, speakers from outside IRB Barcelona will be invited to give presentations, thus providing participants an insightful view into career options after IRB Barcelona. 

Objectives:

- To present scientific data (oral presentation or poster)

- To discuss data presented by students

- To enhance interaction between students

29 Mar 2019

Organizers: IRB Barcelona
Date: Friday 29th March, 12.00h
Place: AUDITORIUM, Parc Cientific de Barcelona

Host: Patrick Aloy, PhD - IRB Barcelona

Abstract

2 Apr 2019 - 11 Apr 2019

Organizer: IRB Barcelona 

Date:  April 2-4-10-11, 09:30-12:00h
Place: Room Felix Serratosa, Parc Científic de Barcelona, Spain

 

8 Apr 2019 - 10 Apr 2019

Cancer is a multi-hit process involving mutations in oncogenes and tumour suppressors. It is altered by its environment including interactions between the tumour cells and the surrounding normal tissue, immune response, and whole body metabolism. As such, cancer studies benefit from whole animal platforms. The fruit fly Drosophila is an excellent, genetically-tractable system for modelling the development of cancer due to the conservation of cell signalling, proliferation, and survival networks between fly and human.

31 May 2019

Organizers: IRB Barcelona
Date: Friday 31 May, 12.00h
Place: Felix Serratosa Hall, Parc Cientific de Barcelona

Host: Ángel R. Nebreda, PhD - IRB Barcelona

Abstract

14 Jun 2019

Organizers: IRB Barcelona
Date: Friday 14 June, 12.00h
Place: Felix Serratosa Hall, Parc Cientific de Barcelona

Host: Cayetano González, PhD - IRB Barcelona

Abstract

18 Nov 2019 - 20 Nov 2019

Stimulation of the immune system by blocking immunosuppressive checkpoints has shown spectacular impact in cancer therapy. There is increasing evidence that immunotherapy might elicit similar outcomes in non-oncological settings. This is the case, for example, of neurodegenerative disorders where blockade of immune checkpoints has beneficial effects.  More generally, aging is associated with a progressive unbalance in the composition and activity of the different components of the immune system.